Join us this evening April 23, 2019 at 7:00 pm CST!

5:00pm PST..6:00pm MST..7:00pm CST..8:00pm EST

→Listen Live →HERE←

Call in # 917-388-4520

Press 1 to speak to the host

Hosted by Arlene Mullin and Greg Coleman

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Advances are being made in dialysis which could vastly improve dialysis treatment for patients.  Join us this evening as we discuss alternatives to the current practices and issues surrounding dialysis treatments that could improve the quality of care and life for dialysis patients.

”

Abstract – Single-access Flexible Dual-lumen Vascular Access Device

“There are approximately 2 million worldwide, 700,000 US patients suffering from End Stage Renal Disease. The predominant treatment approach (~85% of ESRD patients is hemodialysis (HD) treatment from 3-4 times or more per week (compared to 10-15% use of PD). The current HD best practice uses two needles in two cannulation sites (one for withdrawing blood and one for returning treated blood) on the patient’s vascular access. The “best practice” outcome is often compromised by the following complications or limitations:

• Patient pain, discomfort and bleeding from repeated multiple cannulation and forming pseudo-aneurism from cannulation at the same spot (common when there is limited space for two needles)
• Long treatment times resulting from low blood flow rate between two needles
• Only one adequate cannulation site in the fistula, requiring use of catheters which are more costly and more prone to infection.

This proposal addresses an improvement to current best practice that accomplishes significant patient quality of life and comfort, economic, and medical benefits. While other longer term solutions are under development, this proposed innovation can be quickly adopted to reap these patient, economic, and medical benefits”

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Arlene Mullin — advocate, 20 years experience guiding patients and their families through all aspects of End Stage Renal Disease and treatments.  Mullin has served patients in a majority of states, engaging both Medicare and state health authorities towards resolution of quality care issues at clinics.  Comprehensive knowledge of care issues on clinic level.  She was instrumental in getting the hearings on aging before the U.S. Senate in 2000 where she testified on patient care issue within the dialysis industry.

https://dialysisadvocates.com/committed-advocacy/

Dialysis Advocates is grateful for the opportunity to get this important message out for all Dialysis Patients.

We will be having a guest on the first part of every show. Then we will open the Microphones for the Town Hall. Patients and others will be able to discuss concerns and solutions. It will be a patient group, including families.